Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis.

HARE MT: Delivery Strategies Stabilin antisense oligonucleotide endocytosis endosome escape galectin

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
12 Sep 2023
Historique:
received: 31 10 2022
accepted: 17 07 2023
medline: 14 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

Non-DNA-binding Stabilin-2/HARE receptors expressed on liver sinusoidal endothelial cells specifically bind to and internalize several classes of phosphorothioate antisense oligonucleotides (PS-ASOs). After Stabilin-mediated uptake, PS-ASOs are trafficked within endosomes (>97%-99%), ultimately resulting in destruction in the lysosome. The ASO entrapment in endosomes lowers therapeutic efficacy, thereby increasing the overall dose for patients. Here, we use confocal microscopy to characterize the intracellular route transverse by PS-ASOs after Stabilin receptor-mediated uptake in stable recombinant Stabilin-1 and -2 cell lines. We found that PS-ASOs as well as the Stabilin-2 receptor transverse the classic path: clathrin-coated vesicle-early endosome-late endosome-lysosome. Chloroquine exposure facilitated endosomal escape of PS-ASOs leading to target knockdown by more than 50% as compared to untreated cells, resulting in increased PS-ASO efficacy. We also characterize cytosolic galectins as novel contributor for PS-ASO escape. Galectins knockdown enhances ASO efficacy by more than 60% by modulating EEA1, Rab5C, and Rab7A mRNA expression, leading to a delay in the endosomal vesicle maturation process. Collectively, our results provide additional insight for increasing PS-ASO efficacy by enhancing endosomal escape, which can further be utilized for other nucleic acid-based modalities.

Identifiants

pubmed: 37575283
doi: 10.1016/j.omtn.2023.07.019
pii: S2162-2531(23)00192-0
pmc: PMC10412722
doi:

Types de publication

Journal Article

Langues

eng

Pagination

430-443

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM113126
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM147913
Pays : United States

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Annu Rev Biochem. 2009;78:857-902
pubmed: 19317650
J Biol Chem. 2007 Feb 2;282(5):2785-97
pubmed: 17145755
Nucleic Acid Ther. 2022 Oct;32(5):361-368
pubmed: 35612432
Nucleic Acids Res. 2020 Feb 20;48(3):1372-1391
pubmed: 31840180
Biomed Pharmacother. 2022 Dec;156:113987
pubmed: 36411654
Nucleic Acid Ther. 2014 Apr;24(2):101-13
pubmed: 24383421
Nucleic Acids Res. 2020 Dec 2;48(21):11827-11844
pubmed: 32808038
Cells. 2021 May 05;10(5):
pubmed: 34063063
Nat Rev Neurol. 2018 Jan;14(1):9-21
pubmed: 29192260
Front Med (Lausanne). 2021 Oct 27;8:744518
pubmed: 34778306
Biochim Biophys Acta. 2002 Sep 19;1572(2-3):263-73
pubmed: 12223274
Nat Rev Mol Cell Biol. 2007 Aug;8(8):603-12
pubmed: 17609668
Traffic. 2011 Aug;12(8):956-62
pubmed: 21463456
J Biol Chem. 2000 Dec 1;275(48):37733-41
pubmed: 10952975
Adv Drug Deliv Rev. 2015 Jun 29;87:46-51
pubmed: 25666165
Bioconjug Chem. 2012 Feb 15;23(2):147-57
pubmed: 21992697
Nucleic Acid Ther. 2018 Apr;28(2):86-96
pubmed: 29437530
Mol Oncol. 2022 Mar;16(5):1091-1118
pubmed: 34748271
Nat Biotechnol. 2015 Aug;33(8):870-6
pubmed: 26192320
Cells. 2020 Sep 07;9(9):
pubmed: 32906744
J Biol Chem. 2014 Aug 8;289(32):21807-17
pubmed: 24942734
J Clin Med. 2020 Jun 26;9(6):
pubmed: 32604776
Nucleic Acids Res. 2021 Jan 11;49(1):1-14
pubmed: 33275144
Front Pharmacol. 2019 Mar 29;10:305
pubmed: 30983999
Nucleic Acids Res. 2016 Apr 7;44(6):2782-94
pubmed: 26908652
Nat Commun. 2020 Apr 14;11(1):1809
pubmed: 32286269
Atherosclerosis. 2005 Sep;182(1):1-15
pubmed: 15904923
J Control Release. 2011 May 10;151(3):220-8
pubmed: 21078351
Nucleic Acids Res. 2018 Feb 28;46(4):1584-1600
pubmed: 29240946
Pract Neurol. 2018 Apr;18(2):126-131
pubmed: 29455156
J Cell Biol. 1982 Nov;95(2 Pt 1):676-81
pubmed: 6183281
J Pathol. 2012 Jan;226(2):365-79
pubmed: 22069063
Biomedicines. 2021 May 05;9(5):
pubmed: 34063104
Front Bioeng Biotechnol. 2021 Mar 18;9:628137
pubmed: 33816449
J Mater Chem B. 2018 Nov 21;6(43):6904-6918
pubmed: 32254575
Sci Rep. 2016 Sep 08;6:32301
pubmed: 27604151
Nucleic Acids Res. 2016 Aug 19;44(14):6518-48
pubmed: 27084936
Nucleic Acids Res. 2015 Mar 11;43(5):2927-45
pubmed: 25712094
Pharm Res. 2010 Dec;27(12):2556-68
pubmed: 20730557
Bioconjug Chem. 2002 Sep-Oct;13(5):975-84
pubmed: 12236779
Adv Drug Deliv Rev. 2015 Jun 29;87:35-45
pubmed: 25881722
Annu Rev Pharmacol Toxicol. 2010;50:259-93
pubmed: 20055705
EMBO J. 2011 Aug 31;30(17):3481-500
pubmed: 21878991
Nucleic Acids Res. 2018 Nov 2;46(19):10225-10245
pubmed: 30239896
J Vis Exp. 2018 Feb 12;(132):
pubmed: 29553556
Nucleic Acids Res. 2016 Sep 6;44(15):7314-30
pubmed: 27378781
J Leukoc Biol. 2004 Dec;76(6):1151-61
pubmed: 15345724
J Biol Chem. 2004 Aug 27;279(35):36201-9
pubmed: 15208308
J Med Chem. 2012 Jun 14;55(11):5121-9
pubmed: 22575017
Curr Opin Cell Biol. 2013 Aug;25(4):414-9
pubmed: 23639309
Int J Mol Sci. 2018 Feb 01;19(2):
pubmed: 29389859
Med Sci Monit. 2020 Aug 03;26:e923901
pubmed: 32744262
Exp Cell Res. 2005 Feb 1;303(1):160-73
pubmed: 15572036
Biochem Soc Trans. 2020 Dec 18;48(6):2377-2386
pubmed: 33300959
Commun Biol. 2021 Feb 16;4(1):211
pubmed: 33594247
J Med Chem. 2006 Nov 2;49(22):6522-31
pubmed: 17064070
Nucleic Acids Res. 2021 Aug 20;49(14):8277-8293
pubmed: 34244781
J Cell Sci. 2018 May 1;131(9):
pubmed: 29717004
Biomolecules. 2019 Jul 11;9(7):
pubmed: 31336723
J Drug Target. 2013 Jan;21(1):27-43
pubmed: 23163768
Glycobiology. 2008 Aug;18(8):638-48
pubmed: 18499864
Nat Biotechnol. 2017 Mar;35(3):230-237
pubmed: 28244996
Nucleic Acids Res. 2015 Oct 15;43(18):8664-72
pubmed: 26400165
J Biol Chem. 2012 Jun 15;287(25):20774-83
pubmed: 22547069
Biophys J. 2005 Oct;89(4):2286-95
pubmed: 16055530

Auteurs

Ekta Pandey (E)

University of Nebraska, Department of Biochemistry, Beadle Center, 1901 Vine St., Lincoln, NE 68588, USA.

Edward N Harris (EN)

University of Nebraska, Department of Biochemistry, Beadle Center, 1901 Vine St., Lincoln, NE 68588, USA.

Classifications MeSH